Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Hendrik Schulze-Koops and Alla Skapenko.
Hendrik Schulze-Koops
Connection Strength
2.940
Alla Skapenko
  1. Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines. RMD Open. 2021 02; 7(1).
    View in: PubMed
    Score: 0.927
  2. Treatment of patients with inflammatory rheumatic diseases with rituximab should be carefully considered during the SARS-CoV-2/COVID-19 pandemic. Response to: 'Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possible effect of rituximab according to the hypothesis of Schulze-Koops et al' by Benucci et al. Ann Rheum Dis. 2020 Aug 04.
    View in: PubMed
    Score: 0.896
  3. Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab. Ann Rheum Dis. 2021 05; 80(5):e67.
    View in: PubMed
    Score: 0.889
  4. Correspondence to 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'. Ann Rheum Dis. 2020 Oct 30.
    View in: PubMed
    Score: 0.228
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.